• English (English)
Locust Walk
  • About Us
    • Engaging with Us
    • Expertise & Due Diligence
    • Our Team
      • Leadership
      • Advisory Board
  • Our Capabilities
    • How We Work
    • Strategy Consulting
    • Capital Markets
    • Strategic Transactions
    • NewCo Creation
  • Our Transactions
  • Insights
    • Thought Leadership
    • Webinars & Panels
    • News
  • Careers
    • Our Careers
    • Our Core Values
    • Our Culture
    • Our Community Support
  • Contact Us
Select Page

Categories

  • Asian Capabilities
  • Capital Raising
  • Commercial Assessment
  • Locust Walk Institute
  • Market Trends
  • Multitrack Process
  • Negotiation
  • Partnering
  • Quarterly Reports
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008

Time Will Kill Your Deal…but in Deal-Making, Timing is Everything (Part Two)

Sep 17, 2013

In part one of this blog series, we emphasized the importance and potential impact of early outreach on partnering for early-stage biotech companies. Let’s turn our attention now to another setting where timing can favorably and significantly impact the deal process –...

Time Will Kill Your Deal…but in Deal-Making, Timing is Everything (Part One)

Sep 3, 2013

For the moment, let’s put aside the en fuego (but soon to combust?) nature of the biotech IPO market and parallel frothiness (but for how long?) of orphan disease drug development. Our recent transaction efforts stimulated some thoughts on the impact of time, and more...

Geoff Meyerson was a speaker at “The 2013 mHealth Prognosis” Panel Discussion

Jun 26, 2013

Geoff Meyerson spoke at and participated in the Panel Discussion, “The 2013 mHealth Prognosis: Converging Business and Legal Trends,” which was held at 100 Bodek Lounge at the University of Pennsylvania on June 26, 2013 at 5:30 pm. Locust Walk Partners, Wharton Health...

Locust Walk Partners Appoints Chris Ehrlich Managing Director, Establishes Footprint in Bay Area

May 14, 2013

Locust Walk Partners, LLC, a transaction advisory firm that supports biopharmaceutical companies, is pleased to announce that biotech industry and venture capital veteran Chris Ehrlich has joined the firm as Managing Director.  Based in San Francisco, Mr. Ehrlich will...

BOSTON

200 Clarendon Street
51st Floor
Boston, MA 02116

info@locustwalk.com

Privacy Policy

Terms of Use

NEW YORK

420 Lexington Avenue
Suite 2515
New York, NY 10170

LONDON

20 Eastbourne Terrace
London W2 6LG, UK

TOKYO

PMO Nihonbashi Muromachi 3F
1-13-7 Nihonbashi Muromachi
Chuo-ku, Japan 103-0022

SAN FRANCISCO

580 California Street
12th & 16th Floors
San Francisco, CA 94104

  • LinkedIn
  • Twitter
  • YouTube

Designed by Gill Fishman Associates